Use this form to give us your feedback or report any problems you experienced finding information on our Website.
* Indicates Required Fields
Thank you for providing feedback.
|Issue||Coupon (%)||Maturity||Assets (%)|
|Micron Technology, Inc.||3.0||11/15/2043||4.5|
|MGIC Investment Corp.||5.0||05/01/2017||4.1|
|Gilead Sciences, Inc.||1.6||05/01/2016||3.5|
|Wells Fargo & Co.||7.5||1.8|
|Continental Airlines Class C||4.5||01/15/2015||1.8|
|Clearwire Communications LLC||8.3||12/01/2040||1.8|
|Salix Pharmaceuticals, Inc.||1.5||03/15/2019||1.8|
|% of Total Assets||27.1|
|Number of Issues||103|
|Average Maturity||7.65 Years|
|Total Net Assets||$688.04 M|
Performance data quoted is historical. Past performance is not indicative of future results. Current performance may be higher or lower than the performance quoted. The investment return and principal value of an investment in the Fund will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than their original cost. To obtain performance data current to the most recent quarter-end, go to quarter ending performance on our Website or call Lord Abbett at (888) 522-2388.
1 The Fund’s dividend yield is shown without sales charges (at NAV) and with maximum sales charges (at MOP). The Fund’s dividend yield takes into account any fee waiver or expense limitation arrangements, if any. Without such fee waivers or expense limitation arrangements, the Fund’s dividend yield would have been lower. Information regarding any fee waivers or expense limitation arrangements applicable to the Fund is provided with the Fund’s expense ratio information.
2 The Fund’s unsubsidized dividend yield is shown without sales charges (at NAV) and with maximum sales charges (at MOP). The Fund’s unsubsidized dividend yield reflects what the yield would have been without the effect of fee waivers or expense limitation arrangements.